Pancreatic regenerating protein I in chronic pancreatitis and aging: Implications for new therapeutic approaches to diabetes

Pancreas

Volumn 37, Issue 4, 2008, Pages 386-395

  Bluth, Martin ^a   Mueller, Cathy M ^a   Pierre, Joelle ^a   Callender, Gordon ^a   Kandil, Emad ^a   Viterbo, Domenico ^a   Fu, Sophia L ^a   Sugawara, Akira ^a   Okamoto, Hiroshi ^b   Zenilman, Michael E ^a  

^a Downstate Health Sciences University   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Diabetes; Ductal ligation; Pancreas; Reg, therapy; Regeneration protein

Indexed keywords

ANTIBODY; GLUCOSE; INSULIN; PANCREATIC REGENERATING PROTEIN 1; PANCREATIC REGENERATING PROTEIN 1 RECEPTOR; RECEPTOR SUBTYPE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; LITHOSTATHINE; MESSENGER RNA; REG I RECEPTOR, RAT; REG1 PROTEIN, RAT;

ACINAR CELL; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATROPHY; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; IMPAIRED GLUCOSE TOLERANCE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PANCREAS DUCT LIGATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TISSUE LEVEL; ANIMAL; DISEASE MODEL; DRUG EFFECT; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; LIGATION; METABOLISM; PANCREAS; PANCREAS DUCT; PATHOLOGY; WISTAR RAT;

AGING; ANIMALS; ATROPHY; BLOOD GLUCOSE; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; FEMALE; GLUCOSE INTOLERANCE; INJECTIONS, INTRAPERITONEAL; INSULIN; LIGATION; LITHOSTATHINE; PANCREAS; PANCREATIC DUCTS; PANCREATITIS, CHRONIC; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 58149156509     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31817f7893     Document Type: Article

References (46)

1. Shamburek RD, Scott RB, Farrar JT. Gastrointestinal and liver changes in the elderly. In: Katlic MR, ed. Geriatric Surgery: Comprehensive Care of the Elderly Patient. Baltimore, MD: Urban and Schwarzenberg; 1990: 97-115.
2. Owyang C. Endocrine changes in pancreatic insufficiency. In: Go VLW, Dimangno EP, Gardner JD, et al., eds. The Pancreas: Biology, Pathobiology and Disease. 2nd ed. New York, NY: Raven Press; 1993:803-813.
3. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta, GA: US Dept of Health and Human Services; 2005.
4. Zenilman ME, Magnuson TH, Swinson K, et al. Pancreatic thread protein is mitogenic to pancreatic-derived cells in culture. Gastroenterology. 1996;110:1208-1214.
5. Levine JL, Patel KJ, Zheng Q, et al. Arecombinant rat regenerating protein is mitogenic to pancreatic derived cells. J Surg Res. 2005;89:60-65.
6. Bluth MH, Patel SA, Dieckgraefe BK, et al. Pancreatic regenerating protein (reg I) and reg I receptor mRNA are upregulated in rat pancreas after induction of acute pancreatitis. World J Gastroenterol. 2006; 12:4511-4516.
7. Zenilman ME, Chen J, Magnuson TH. Effect of reg protein on rat pancreatic ductal cells. Pancreas. 1998;17:256-261.
8. Watanabe T, Yonemura T, Yonekura H, et al. Pancreatic beta-cell replication and amelioration of surgical diabetes by reg protein. Proc Natl Acad Sci U S A. 1994;91:3589-3592.
9. Gross DJ, Weiss L, Reibstein I, et al. Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with reg protein treatment. Endocrinology. 1998;139:2369-2374.
10. Kobayashi S, Akiyama T, Nata K, et al. Identification of a receptor for reg (regenerating gene) protein, a pancreatic beta-cell regeneration factor. J Biol Chem. 2000;275:10723-10726.
11. Sanchez D, Gmyr V, Kerr-Conte J, et al. Implication of Reg I in human pancreatic duct-like cells in vivo in the pathological pancreas and in vitro during exocrine dedifferentiation. Pancreas. 2004;29:14-21.
12. Boquist L, Edstrom C. Ultrastructure of pancreatic acinar and islet parenchyma at various intervals after duct ligation. Virchows Arch A Pathol Pathol Anat. 1970;349:69-79.
13. Edstrom C, Falkmer S. Qualitative and quantitative morphology of the rat pancreatic islet tissue five weeks after ligation of the pancreatic ducts. Acta Soc Med Ups. 1967;72:376-390.
14. Hultquist GT, Karlsson U, Hallner AC. The regenerative capacity of the pancreas in duct-ligated rats. Exp Pathol (Jena). 1979;17:44-52.
15. Edstrom C, Falkmer S. Pancreatic morphology and blood glucose levels in rats at various intervals after duct ligation. Virchows Arch Abt A Path Anat. 1968;345:139-153.
16. Hultquist GT, Jonsson LE. Ligation of the pancreatic duct in rats. Acta Soc Med Ups. 1965;70:82-88.
17. Edstrom C. Glucose tolerance of rats at various intervals following ligation of the pancreatic ducts. Acta Soc Med Ups. 1971;76:39-48.
18. Kandil E, Lin YY, Bluth MH, et al. Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins. World J Gastroenterol. 2006;12:6806-6811.
19. Zenilman ME, Tuchman D, Zheng Qh, et al. Comparison of pancreatic reg I and reg III levels in acute pancreatitis. Ann Surg. 2000;232:646-652.
20. Tezel E, Nagasaka T, Tezel G, et al. REG I as a marker for human pancreatic acinoductular cells. Hepatogastroenterology. 2004;51:91-96.
21. Unno M, Yonekura H, Nakagawara K, et al. Structure, chromosomal localization, and expression of mouse reg genes, reg I and reg II. A novel type of reg gene, reg II, exists in the mouse genome. J Biol Chem. 1993;268:15974-15982.
22. Zhang H, Kandil E, Lin YY, et al. Targeted inhibition of gene expression of pancreatitis-associated proteins exacerbates the severity of acute pancreatitis in rats. Scand J Gastroenterol. 2004;39:870-881.
23. Pierre J, Mueller CM, Viterbo D, et al. Pancreatic regeneration protein (Reg) modulates glucose tolerance testing. J Surg Res. 2007;131:313.
24. Idezuki Y, Goetz FC, Lillehei RC. Late effect of pancreatic duct ligation on A-cell function. Am J Surg. 1969;117:33-39.
25. Kloppel G, Bommer G, Commandeur G, et al. The endocrine pancreas in chronic pancreatitis. Immunocytochemical and ultrastructural studies. Virchows Arch A Pathol Anat Histol. 1978;377:157-174.
26. Rosenberg L, Duguid WP, Brown RA, et al. Induction of nesidioblastosis will reverse diabetes in Syrian golden hamster. Diabetes. 1988;37: 334-341.
27. Lillemoe KD. Pancreatic disease in the elderly patient. Surg Clin North Am. 1994;74:317-344.
28. Hellerstrom C. The life story of the pancreatic β-cell. Diabetologia. 1984;26:393-400.
29. Dragstedt LR. Some physiologic problems in surgery of the pancreas. Ann Surg. 1943;118:576-593.
30. Yeo CJ, Bastidas JA, Schmeig RE, et al. Pancreatic structure and glucose tolerance in a longitudinal study of experimental pancreatitis-induced diabetes. Ann Surg. 1989;210:150-158.
31. Gooszen HG, Schilfgaarde RV, van der Burg MPM, et al. Quantitative assessment of long-term changes in insulin secretion after canine duct-obliterated pancreas transplantation. Transplantation. 1988;46: 793-799.
32. Perfetti R, Raydada M, Wang Y, et al. Reg and insulin genes are expressed in prepancreatic mouse embryos. J Mol Endocrinol. 1996;17:1-10.
33. Unno M, Itoh T, Watanabe T, et al. Islet beta-cell regeneration and reg genes. Adv Exp Med Biol. 1992;321:61-69.
34. Zenilman ME, Perfetti R, Swinson K, et al. Pancreatic regeneration (reg) gene expression in a rat model of islet hyperplasia. Surgery. 1996; 119:576-584.
35. Planas R, Alba A, Carrillo J, et al. Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: role of IFNbeta. Diabetologia. 2006;49:2379-2387.
36. Baeza N, Sanchez D, Vialettes B, et al. Specific reg II gene overexpression in the non-obese diabetic mouse pancreas during active diabetogenesis. FEBS Lett. 1997;416:364-368.
37. Shervani NJ, Takasawa S, Uchigata Y, et al. Autoantibodies to REG, a beta-cell regeneration factor, in diabetic patients. Eur J Clin Invest. 2004;34:752-758.
38. Unno M, Nata K, Noguchi N, et al. Production and characterization of Reg knockout mice: reduced proliferation of pancreatic beta-cells in Reg knockout mice. Diabetes. 2002;51:S478-S483.
39. Yamaoka T, Yoshino K, Yamada T, et al. Diabetes and tumor formation in transgenic mice expressing Reg I. Biochem Biophys Res Commun. w2000;278:368-376.
40. Zenilman ME, Zheng Q, Wu H, et al. Pancreatic reg and a conserved bioactive fragment are mitogenic through the MAPK p38 pathway. Surg Forum. 2000;LI:33-34.
41. Wu H, Fan Z, Patel SA, et al. Expression of reg receptor in rat pancreatic cell lines. Gastroenterology. 2001;120:A338.
42. Okamoto H, Takasawa S. Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in beta-cells. Diabetes. 2002;51:S462-S473.
43. Rafaeloff R, Pittenger GL, Barlow SW, et al. Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J Clin Invest. 1997;99: 2100-2109.
44. Taylor-Fishwick DA, Rittman S, Kendall H, et al. Cloning genomic INGAP: a Reg-related family member with distinct transcriptional regulation sites. Biochim Biophys Acta. 2003;1638:83-89.
45. Rosenberg L, Lipsett M, Yoon JW, et al. A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice. Ann Surg. 2004;240:875-884.
46. Pierre J, Mueller CM, Bernstein E, et al. The effect of REG administration on glycosylated hemoglobin in aged rats. J Surg Res. 2008;144:376.